A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 1 982,15 Kč, with a 24-hour trading volume of 119,38M Kč. The asset's market cap is 6,14T Kč, after moving 0.74% in the last day.
Tokenized AstraZeneca PLC is trading at 1 988,9 Kč, with a tokenized market cap of 14,91M Kč and a 24-hour trading volume of 1,52M Kč. The tokenized asset has moved 0.40% in the past 24 hours.